View Information Collection Request (ICR) Package

Please note that the OMB number and expiration date may not have been determined when this Information Collection Request and associated Information Collection forms were submitted to OMB. The approved OMB number and expiration date may be found by clicking on the Notice of Action link below.

View ICR - OIRA Conclusion

OMB Control No: 0920-0978	ICR Reference No: 201801-0920-004
Status: Historical Active	Previous ICR Reference No: 201705-0920-001
Agency/Subagency: HHS/CDC	Agency Tracking No: 0920-0978-18LX
Title: Emerging Infections Program
Type of Information Collection: No material or nonsubstantive change to a currently approved collection	Common Form ICR: No
Type of Review Request: Regular
OIRA Conclusion Action: Approved without change	Conclusion Date: 01/29/2018
Retrieve Notice of Action (NOA)	Date Received in OIRA: 01/24/2018
Terms of Clearance: Previous terms continue: Approved consistent with the understanding that this consolidation will result in the modification and/or discontinuation of related CDC ICRs.

	Inventory as of this Action	Requested	Previously Approved
Expiration Date	02/28/2019	02/28/2019	02/28/2019
Responses	62,820	0	80,420
Time Burden (Hours)	22,090	0	22,473
Cost Burden (Dollars)	0	0	0

ICR Summary of Burden

	Total Approved	Previously Approved	Change Due to Agency Discretion
Annual Number of Responses	62,820	80,420	-17,600
Annual Time Burden (Hours)	22,090	22,473	-383
Annual Cost Burden (Dollars)	0	0	0

Burden increases because of Program Change due to Agency Discretion: Yes

Burden Increase Due to: Miscellaneous Actions

Burden decreases because of Program Change due to Agency Discretion: Yes

Burden Reduction Due to: Changing Forms

Short Statement: The submission of this Non-Substantive Change Request entails an overall decrease in Burden Hours due to the changes in the following forms associated with 0920-0978 Emerging Infections Program: 2018 Resistant Gram-Negative Bacilli (MuGSI) Case Report Form 2018 Invasive Methicillin-resistant Staphylococcus aureus (MRSA) Infection Case Report Form 2018 Clostridium difficile Infection (CDI) Case Report Form Additionally the following instruments were discontinued: Clostridium difficile infection (CDI): Screening Form Clostridium difficile infection (CDI): Telephone Interview Form

Annual Cost to Federal Government: $20,221,865

Does this IC contain surveys, censuses, or employ statistical methods? Yes Part B of Supporting Statement

Does this ICR request any personally identifiable information (see OMB Circular No. A-130 for an explanation of this term)? Please consult with your agency's privacy program when making this determination. No

Does this ICR include a form that requires a Privacy Act Statement (see 5 U.S.C. §552a(e)(3))? Please consult with your agency's privacy program when making this determination. No

Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]? No

Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]? No

Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)? No

Is this ICR related to the Pandemic Response? Uncollected

Agency Contact: Jeffrey Zirger 404 639-7118 wtj5@cdc.gov